Gießen (ots) - - Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine - Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields The nomination period ...To the press release of Asklepios Kliniken GmbH & Co. KGaA

Munich (ots/PRNewswire) - Aescuvest Capital Partners (ACP) is at the forefront of Healthtech investing, leveraging its deep expertise in European healthcare innovation to make a global impact. With a focus on companies nearing pivotal MDR and FDA ...To the press release of Aescuvest Capital Partners

Tel Aviv, Israel (ots/PRNewswire) - The Autonomous Sperm Selection AI-based Robotic System is Poised to Transform the IVF Market BAIBYS™, a pioneering Israeli startup in AI-powered micro-robotics for Artificial Reproductive Technology (ART), today ...To the press release of BAIBYS

Andernach (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company, is proud to announces its selection as a Concept Stage winner for two projects in the #PatchForwardPrize, a $50 million challenge by the ...To the press release of LTS Lohmann Therapie-Systeme AG

Waiblingen (ots) - The test covers the most important bacterial pathogens across all age groups with a single cartridge - The Vivalytic test is a PCR rapid test that specifically detects the six most common causes of bacterial meningitis in under an ...To the press release of Bosch Healthcare Solutions GmbH

Aachen, Germany (ots) - Grünenthal announced today that Prof. Dr. Uli Brödl will assume the role of Chief Scientific Officer (CSO) and Member of the Corporate Executive Board, effective 01 February 2025. Uli Brödl has more than 15 years of ...To the press release of Grünenthal Group

Porto, Portugal (ots/PRNewswire) - BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE Phase 2 study. ...To the press release of BIAL SA

London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This ...To the press release of Norgine

Heidelberg, Germany (ots) - - EMA approves blinded, multi-centric Phase-3 trial (NCT06489028) to investigate the safety and efficacy of allo-APZ2-CVU in patients with CVU - Decision follows FDA approval and is based on positive results from ...To the press release of RHEACELL GmbH und Co. KG

Düsseldorf (ots) - - Innovative combination product of furosemide and on-body device - Ready-to-market device designed, developed and manufactured by Gerresheimer - Patented device technology for precise administration Gerresheimer, an innovative ...To the press release of Gerresheimer AG

London (ots/PRNewswire) - - Accord announces that the European Commission (EC has granted marketing authorisation for Imuldosa® (development code: DMB-3115), a biosimilar to Stelara®, indicated for a range of immune medicated inflammatory ...To the press release of Accord Healthcare

Freising (ots) - Why is the cultivation of regional foods crucial for reducing carbon dioxide emissions? How can innovative research on apple varieties help combat allergies? Dr. Clemens Röhrl, project leader of the Interreg-funded Regio-Plants ...To the press release of EU4Regions

Zug, Switzerland (ots) - - Market proximity of Strides Pharma International AG, based in Zug, Switzerland, opens the way for rapid technology transfer and innovation within the European market - Oren Weininger, longstanding leader at Fairmed ...To the press release of Strides Pharma International AG

Frankfurt am Main (ots) - The European Patient Congress Depression, hosted by the European Alliance Against Depression (EAAD), will take place on December 7, 2024. This free online-event is designed to support individuals affected by depression and ...To the press release of European Alliance Against Depression

Zug, Switzerland (ots) - SHL Medical, a world leader in self-injection solutions, today announced plans to establish SHL Advantec – a dynamic sub-group dedicated to providing tooling and automation solutions to the healthcare sector and other ...To the press release of SHL Medical

Aachen, Germany/Morristown, N.J. (ots) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], ...To the press release of Grünenthal Group

Ramat Gan, Israel (ots/PRNewswire) - Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel's largest HMO. Over the ...To the press release of Pulsenmore Ltd.

Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to ...To the press release of Grünenthal Group

Caesarea, Israel (ots/PRNewswire) - Epitomee Medical Ltd. (TASE: EPIT) announces today that the company leadership intends to present Epitomee's Oral Delivery of Biologics Platform at the 14th Annual PODD Conference - Partnership Opportunities in ...To the press release of Epitomee Medical

Berlin/Gütersloh (ots) - At this year’s World Health Summit in Berlin, the WHO Youth Council presented its vision for healthier societies. The World Health Organization’s Youth Council is calling on policymakers to better leverage the potential ...To the press release of Bertelsmann Stiftung

London (ots/PRNewswire) - Norgine (the "Company"), a leading European specialty pharmaceutical company, has today announced the appointment of Janneke van der Kamp as its new Chief Executive Officer (CEO), effective from 1 January 2025. Current CEO, ...To the press release of Norgine

Berlin (ots) - x-cardiac, a leader in AI-based medical devices for the prediction of postoperative complications after cardiac surgery, is pleased to announce the successful MDR (Medical Device Regulation) certification of its new ...To the press release of x-cardiac GmbH

Berlin (ots) - The financing of WHO, Germany's role in global health, antimicrobial resistance, Mpox, digitalization - topics like these are on the agenda of this year's World Health Summit from October 13-15 in Berlin. Leading international experts ...To the press release of World Health Summit

Tel Aviv, Israel (ots/PRNewswire) - MSD, a leading multinational pharmaceutical company successfully completes a first-of-its-kind strategic collaboration with Briya, a medical data retrieval network. This groundbreaking partnership enabled ...To the press release of Briya

Heidelberg, Germany (ots) - - FDA approved blinded, multi-centric Phase-3 trial (NCT06489028) to investigate the safety and efficacy of allo-APZ2-CVU in patients with CVU - The study will be conducted at more than 100 sites and is expected to enroll ...To the press release of RHEACELL GmbH und Co. KG

Palo Alto, Calif./Munich, Germany (ots) - You.com, an AI-powered productivity engine, today announced a partnership with Wort & Bild Verlag, Germany's leading health media provider. This collaboration aims to enhance access to health information for ...To the press release of Wort & Bild Verlagsgruppe - Unternehmensmeldungen

Caesarea, Israel (ots/PRNewswire) - Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and ...To the press release of Epitomee Medical

Ejby, Denmark (ots/PRNewswire) - Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization ("CRO"). Gentronix, now integrated into ...To the press release of Scantox A/S

Wilmington, Mass., Miami and Haifa, Israel (ots/PRNewswire) - Collaboration stands to advance novel therapeutic applications across multiple neurologic conditions Charles River Laboratories International, Inc. (NYSE: CRL) and Insightec, a global ...To the press release of INSIGHTEC; Charles River Laboratories International, Inc.

Waiblingen (ots) - - The Vivalytic test is the world's first PCR test for near-patient testing to specifically detect all three whopping cough pathogens: B. pertussis, B. parapertussis, B. holmesii - Pathogen differentiation is crucial for targeted ...To the press release of Bosch Healthcare Solutions GmbH